Eficacia, seguridad y eficiencia de los inmunomoduladores tópicos para la dermatitis atópica

Garside R, Stein K, Castelnuovo E, Pitt M, Ashcroft D, Dimmock P, Payne L.The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation. Health Technol Assess. 2005; 9: 29
National Institute for Clinical Excellence. Tracolimus and pimecrolimus for atopic eczema. Techonology Appraisal 82 (August 2004) [en línea][fecha de consulta: 22-VIII-2006]. Disponible en: http://www.nice.org.uk/page.aspx?o=TA082guidance
Eichenfield LF, Lucky AW, Boguniewicz M, Langley RGB, Cherill R, Marshall K, et al. Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol. 2002; 46: 495-504
Kapp A, Papp K, Bingham A, Folster-Holst R, Ortonne JP, Potter PC, et al. Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory durg. J Allergy Clin Immunol. 2002; 110: 277-84
Wahn U, Bos JD, Goodfield M, Caputo R, Papp K, Manjra A, et al. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics. 2002; 110: e2
Ho VC, Gupta A, Kaufmann R, Todd G, Vanaclocha F, Takaoka R, et al. Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants. J Pediatr. 2003; 142: 155-62
Whalley D, Huels J, McKenna SP, van Assche D. The benefit of pimecrolimus (Elidel, SDZ ASM 981) on parent´s quality of life in the treatment of pediatric atopic dermatitis. Pediatrics. 2002; 110: 1133-6
Kempers S, Boguniewicz M, Carter E, Jarratt M, Pariser D, Stewart D, et al. A randomized investigator-blinded study comparing pimecrolimus cream 1% with tracolimus ointment 0.03% in the treatment of pediatric patient with moderate atopic dermatitis. J Am Acad Dermatol. 2004; 51: 515-25
Ling M, Gottlieb A, Pariser D, Caro I, Stewart D, Soctt G, et al. A randomized study of safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis. J Dermatolog Treat. 2005; 16: 142-8
Staab D, Kaufamann R, Bräutigam M, Wahn U; CASMA981CDE04-Study Group. Treatment of infants with atopic eczema with pimecrolimus cream 1% improves parent´s quality of life: a multicenter, randomized trial. Pediatr Allergy Immunol. 2005; 16: 527-33
Papp KA, Werfel T, Folster-Holst R, Ortonne JP, Potter PC, de Prost Y, et al. Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children : a two-year study. J Am Acad Dermatol. 2005; 52: 240-6
Siegfried E, Korman N, Molina C, Kianifard F, Abrams K. Safety and efficacy of early intervention with pimecrolimus cream 1% combined with corticosteroids for major flares in infants and children with atopic dermatitis. J Dermatolog Treat. 2006; 17: 143-50
Lubbe J, Friendlander SF, Cribier B, Morren MA, García-Diez A, Gelmetti C, et al. Safety, efficacy, and dosage of 1% pimecrolimus cream for the treatment of atopic eczema dermatitis in daily practice. Am J Clin Dermatol. 2006; 7: 121-31
Boguniewicz M, Fiedler VC, Raimer S, Lawrence ID, Leung DYM, Hanifin JM. A randomized, vehicle-controlled trial of tracolimus ointment for treatment of atopic dermatitis in children. J Allergy Clin Immunol. 1998; 102: 637-44
Paller A, Eichenfield LF, Leung DYM, Stewart D, Appell M. A 12-week study of tracolimus ointment for the treatment of atopic dermatitis in pediatric patient. J Am Acad Dematol. 2001; 44: S47-57
Reitamo S, Van Leent EJM, Ho V, Harper J, Ruzicka T, Kalimo K, et al. Efficacy and safety of tracolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol. 2002; 109: 539-46
Reitamo S, Harper J, Bos JD, Cambazard F, Bruijnzeel-Koomen C, Valk P, et al. 0.003% tracolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe